ID-Epi Training Program

Steering Committee

The Steering Committee is responsible for the management of the Infectious Disease Epidemiology Training Program, serving both as an Admissions Committee and Leadership Team. The Committee is comprised of ID-Epi researchers and professors with Columbia University and external affiliations. To learn more about the Steering Committee, please choose from among the members listed in the pulldown menu.



Mary Ann Chiasson, Dr.PH.
Associate Professor of Clinical Epidemiology (in Medicine)
Division of Infectious Diseases, Department of Medicine, College of Physicians and Surgeons
Columbia University
Vice President, Research and Evaluation
Public Health Solutions
220 Church Street, 5th Floor
New York, NY 10013-2988
machiasson@healthsolutions.org

Mary Ann Chiasson, Dr.P.H. (Member, Steering Committee) is an Associate Professor of Clinical Epidemiology (in Medicine) at Columbia’s MSPH and P&S.  She is Vice President for Research and Evaluation at Public Health Solutions (PHS), a non-profit organization that provides health-related services, conducts demonstration and research programs, and offers management services in order to improve community health and strengthen health policy.  Before joining PHS, Dr. Chiasson served for fourteen years in various capacities at the New York City Department of Health and Mental Hygiene (NYC DOHMH) including nine years as an Assistant Commissioner of Health with scientific and administrative responsibility for AIDS Surveillance, AIDS Research, and Vital Statistics and Epidemiology.  Dr. Chiasson's primary research interest is in the sexual transmission of HIV and she co-directs the online HIV prevention project for MSM, HIV Is Still,A Big Deal.  She is also interested in the epidemiology of HIV (particularly risk factors for sexual transmission and gynecologic manifestations of HIV), women's reproductive health, infant mortality, and early childhood obesity.  Her current HIV-related research focuses on the relationship between the Internet and high risk sexual behavior among men who have sex with men. She co-founded and co-directs the MSPH course, Epidemiology of HIV/AIDS. She has mentored five postdoctoral ID-EPI trainees (Drs. Ferris, Cutler, Gandhi, Thieu, and Taylor) and is currently mentoring Dr. Myers.



Wafaa El-Sadr. M.D., M.P.H., M.P.A

Professor, Clinical Medicine and Epidemiology
Director, ICAP
Director, Center for Infectious Disease Epidemiologic Research
Mailman School of Public Health
Columbia University
722 West 168th Street
New York, NY 10032
wme1@columbia.edu

Wafaa El-Sadr, M.D., M.P.H., M.P.A (Principal Investigator, Chair of Steering Committee): is a Professor of Medicine and Epidemiology at Columbia University and Director of ICAP and CIDER. During her decades of experience working with researchers and experts from diverse disciplines in the design of research studies and multidisciplinary programs, she has collaborated with social scientists, educators, clinicians, epidemiologists, engineers, policy makers, and health systems researchers, among others. Through the MSPH ICAP and CIDER, founded by Dr. El-Sadr, she has gained extensive experience with domestic and global health programming, research, and training. Dr. El-Sadr has mentored generations of trainees in clinical research, epidemiology, program design and clinical infectious diseases. Drawing on her leadership and management skills, she has headed large teams of researchers and program staff and managed large scale complex grants and contracts, with funding from NIH, CDC, USAID, and foundations, for research and programs from RO1s to large cooperative agreements. She has also chaired and played key roles in various national and international committees and task forces. She is former chair of the NIAID AIDS Research Advisory Committee (ARAC) and is currently a member of the WHO Strategic TB Advisory Group. She chairs the Domestic Prevention Working Group of the HIV Prevention Trials Network (HPTN). She is an elected member of the Institute of Medicine.



Crystal Fuller, Ph.D., M.P.H.
Associate Professor of Clinical Epidemiology
Department of Epidemiology
Mailman School of Public Health
Columbia University
722 West 168th Street
New York, NY 10032
Cf317@columbia.edu

Crystal Fuller, Ph.D., M.P.H. (Co-Director of the Training Program and Member, Steering Committee) has led several federally and privately funded research studies over the past 10 years and served as a co-PI or co-Investigator on several others. Dr. Fuller’s expertise stems from extensive experience in the design, conduct, and analysis of infectious disease and drug abuse epidemiologic studies, particularly structural interventions, with a focus on racial disparities in acquisition of HIV, and social and medical-related consequences. As one of the first NIDA diversity supplement recipients during her doctoral studies, Dr. Fuller has firsthand knowledge of the importance of providing students with quality mentoring and tools to succeed as an independent researcher. In the past 10 years at Columbia, Dr. Fuller has mentored several MPH and doctoral level students as a thesis advisor, dissertation advisor, thesis and dissertation sponsor, reader, and defense committee chair. Dr. Fuller has provided academic guidance for a number of students and junior faculty from underrepresented racial/ ethnic groups as the Chair of the Department of Epidemiology Diversity Committee.



Scott M. Hammer M.D.
Harold C. Neu Professor of Medicine
Professor of Epidemiology
Chief, Division of Infectious Diseases
Division of Infectious Diseases, Department of Medicine, College of Physicians and Surgeons
Columbia University
630 West 168th Street, Ph-8W-876
New York, NY 10032
smh48@columbia.edu

Scott M. Hammer, M.D. (Co-Chair of Steering Committee) is the Harold C. Neu Professor of Medicine, Professor of Epidemiology and Chief of the Division of Infectious Diseases at CUMC.  Dr. Hammer’s major investigative interest is the treatment and prevention of HIV disease.  He is an investigator in the NIH-sponsored AIDS Clinical Trials Group (ACTG), a multicenter organization which performs clinical trials to improve the understanding and treatment of HIV infection and its complications.  Dr. Hammer has chaired several trials of antiretroviral therapy (including ACTG 175 and ACTG 320) which have contributed to the current standard of care of HIV infection.  Dr. Hammer is an investigator in the NIH sponsored HIV Vaccine Trials Network (HVTN) and is the Protocol Chair of HVTN 505, a currently enrolling, phase 2b multicenter clinical trial of a multiclade HIV-1 DNA plasmid vaccine, followed by a multiclade recombinant adenoviral vector vaccine. Dr. Hammer is a former Chair of the AIDS Vaccine Research Working Group of the Division of AIDS, NIAID, and the FDA’s Antiviral Products Advisory Committee.  He has chaired many guideline and advisory groups, including the International AIDS Society-USA’s Antiretroviral Guidelines Panel and Program Committee of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).  As Fellowship Program Director and Chief of the Division of Infectious Diseases, he has trained generations of infectious disease clinical trainees.

 

Andrea Howard, M.D., M.S.
Deputy Director of the Clinical Unit, ICAP
Associate Professor of Clinical Epidemiology
Department of Epidemiology
Mailman School of Public Health
Columbia University
722 West 168th Street
New York, NY 10032
aah2138@columbia.edu

Andrea A. Howard, M.D., M.S. (Co-Director of the Training Program and Member, Steering Committee) is an Associate Professor of Clinical Epidemiology and Deputy Director of the Clinical Unit at ICAP. Her research has focused on the epidemiology of HIV and related infections, including hepatitis C and tuberculosis. She has been a co-investigator on several NIH-funded domestic HIV cohort studies in women and drug users, including the Women’s Interagency HIV Study (WIHS) and the Bronx HIV Epidemiologic Research on Outcomes (HERO) Study. With the support of a K23 award, Dr. Howard led a study of the impact of HIV infection, antiretroviral use, and hepatitis C on diabetes mellitus. Currently she is engaged in several CDC-funded operational research projects evaluating service delivery for tuberculosis and HIV infection in sub-Saharan Africa.  Dr. Howard is an Assistant Attending Physician in Infectious Diseases at Harlem Hospital. She also directs the Infectious Disease Epidemiology course at MSPH, and has mentored several students and postdoctoral trainees in clinical and epidemiological research, including one post-doctoral ID-EPI trainee (Dr. Kessler).



Jessica E. Justman, M.D.
HPTN and MTN CRS Site Leader, Bronx-Lebanon Clinical Research Site
Senior Technical Director, ICAP
Mailman School of Public Health, Columbia University
Associate Professor of Clinical Medicine in Epidemiology
Division of Infectious Diseases, College of Physicians and Surgeons,
Columbia University
722 West 168th Street, Room 714
New York, New York   10032
jj2158@columbia.edu

Jessica Justman, M.D. (Member, Steering Committee) is an Infectious Disease specialist and Associate Director of CIDER.  As a Senior Technical Director at ICAP and Associate Professor of Clinical Medicine (in Epidemiology) Dr. Justman brings knowledge of clinical, monitoring and evaluation, and health systems strengthening activities for HIV prevention, care and treatment programs as well as of clinical laboratory support activities. She also has extensive clinical experience in HIV, TB, and other infectious diseases in an inner-city setting. Her teaching experiences have included a wide range of students, including medical students, medical residents, and infectious disease fellows in the setting of ward rounds and infectious diseases consultation rounds. At MSPH, she has supervised several pre- and postdoctoral students and several masters students. Dr. Justman’s primary research interest is in HIV prevention. She has conducted several HIV prevention trials in collaboration with the HIV Prevention Trials Network (HPTN) and the Microbicide Trials Network (MTN). She is a member of the HPTN Domestic Prevention Working Group and served as Co-Chair of the HPTN’s Women’s HIV Seroincidence Study (ISIS).



Elaine Larson, RN, PhD, FAAN, CIC
Professor of Pharmaceutical and Therapeutic Research              
Associate Dean for Research                                                    
School of Nursing
Professor of Epidemiology
Joseph Mailman School of Public Health
Columbia University
Editor, American Journal of Infection Control (http://www.apic.org/ajic/ <http://www.apic.org/ajic/> )
617 W. 168th St. New York, NY 10032
ELL23@columbia.edu

Elaine Larson, R.N., Ph.D.  (Member, Steering Committee) is Professor of Nursing and Associate Dean. She has degrees in nursing, microbiology and epidemiology. She has been conducting research related to healthcare associated infections and in particular the role of skin flora and hands in transmission from staff to patients for over three decades.  She has served on an NIH study section for behavioral aspects of HIV/AIDS and chaired two task forces for NINR.  She has completed four clinical trials in the acute care setting, examining the effect of various hand hygiene regimens on skin microbiology and the impact of preoperative microbial counts on postoperative surgical site infections. She has conducted a prevalence survey in the local community of the correlation between home hygiene practices and the prevalence of infectious diseases in households. She currently is examining the impact of antibacterial products and hand hygiene regimens on infectious disease prevalence and emergence of antiseptic resistance.  Dr. Larson has mentored two trainees in the ID-EPI Training Program (Dr. Furuya and Allison Aiello).  She is the PI of an NIH-funded training program, “Training in Interdisciplinary Research to Reduce Antimicrobial Resistance (TIRAR)”.    



Stephen S. Morse, Ph.D., FAAM
Director, USAID Emerging Pandemic Threats - PREDICT Program
Professor of Clinical Epidemiology
Department of Epidemiology
Mailman School of Public Health
Columbia University
722 West 168th Street, #1504
New York, NY 10032
Visiting Professor
University of California Davis
School of Veterinary Medicine
ssm20@columbia.edu

Stephen Morse, Ph.D. (Member, Steering Committee) is Professor of Clinical Epidemiology at MSPH, and Director of the PREDICT project of the USAID Emerging Pandemic Threats (EPT) program.  He was also Founding Director of the Columbia University Center for Public Health Preparedness. He has co-directed Columbia’s Communicable Disease Epidemiology course, and developed and has taught an epidemiology graduate course in Emerging Infectious Disea   ses.  He has extensive experience with both emerging infections and defense against bioterrorism.  He was the founding Chair of ProMED (the nonprofit international Program to Monitor Emerging Diseases), serves on several editorial boards, including the CDC journal Emerging Infectious Diseases, Biosecurity and Bioterrorism and EcoHealth, and serves on the Steering Committee of the Institute of Medicine's “Forum on Microbial Threats.”

Simon Tsiouris, MD, MPH
Assistant Professor of Clinical Medicine and Clinical Epidemiology
Assistant Attending Physician in Infectious Diseases at NewYork-Presbyterian Hospital Columbia University Medical Center
Division of Infectious Diseases, Department of Medicine, College of Physicians and Surgeons
Columbia University
630 West 168th Street, Ph-8W-876
New York, NY 10032
st326@columbia.edu

Simon Tsiouris, MD, MPH, (Member, Steering Committee) is an Assistant Professor of Clinical Medicine and Clinical Epidemiology. His research focuses on TB epidemiology in resource-limited settings, TB/HIV co-infection and novel diagnostics for TB.  As a post-doctoral trainee in the ID-EPI Training Program, he was mentored by Dr. El-Sadr and conducted a latent TB infection (LTBI) prevalence survey as well as the evaluation of a new assay for the diagnosis of TB and LTBI in a high HIV prevalence area.  Dr. Tsiouris co-directs the Department of Epidemiology’s course on the Epidemiology and Control of TB. He is an Assistant Attending Physician in Infectious Diseases at NewYork-Presbyterian Hospital Columbia University Medical Center. He currently mentors multiple MPH and PhD students. His experience as a graduate of the ID-EPI Training Program provides added depth to the Steering Committee.



Michael Yin, M.D., M.S.

Assistant Professor of Clinical Medicine
Division of Infectious Diseases, Department of Medicine, College of Physicians and Surgeons
Columbia University
630 West 168th Street, Ph-8W-876
New York, NY 10032
mty4@columbia.edu

Michael Yin, M.D., M.S. (Member, Steering Committee) is an Assistant Professor of Clinical Medicine in the Division of Infectious Diseases. Dr Yin's primary research interest is in the metabolic complications of HIV infection and antiretroviral therapy. With support from an NIH/NIAID K23 research career award, he examined the pathogenesis of HIV-associated bone loss in postmenopausal women utilizing novel molecular assays and imaging studies. Currently, he is working to characterize the effect of antiretroviral initiation on bone cells, bone turnover, and bone microarchitecture. He is a member of the Metabolic Complications Working Group for the WIHS and is involved in several studies examining bone metabolism and vitamin D metabolism within the cohort. He is a site investigator in the ACTG and a member of the ACTG Bone Complications Working Group, and the co-chair of A5280, a randomized, double-blind, placebo-controlled clinical trial of high dose vitamin D and calcium to prevent bone loss associated with initiation of fixed-dose emtricitabine/tenofovir/efavirenz in HIV-infected individuals. He is also a site investigator in the HVTN.